Soligenix
SNGX
#10202
Rank
ยฃ9.35 M
Marketcap
ยฃ0.93
Share price
0.82%
Change (1 day)
-49.16%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ7.06 Million a decrease over its 2023 earnings that were of -ยฃ5.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million34.06%
2024 -ยฃ7.06 Million22.96%
2023 -ยฃ5.74 Million-45.74%
2022 -ยฃ10.57 Million11.88%
2021 -ยฃ9.45 Million-32.37%
2020 -ยฃ13.97 Million83.18%
2019 -ยฃ7.63 Million11.57%
2018 -ยฃ6.84 Million19.29%
2017 -ยฃ5.73 Million33%
2016 -ยฃ4.31 Million-19.7%
2015 -ยฃ5.37 Million5.16%
2014 -ยฃ5.11 Million
2010 -ยฃ5.76 Million26.12%
2009 -ยฃ4.57 Million75.1%
2008 -ยฃ2.61 Million-45.38%
2007 -ยฃ4.78 Million-22.84%
2006 -ยฃ6.19 Million66.15%
2005 -ยฃ3.73 Million-16.65%
2004 -ยฃ4.47 Million13.28%
2003 -ยฃ3.95 Million-11.88%
2002 -ยฃ4.48 Million-59.44%
2001 -ยฃ11.04 Million378.18%
2000 -ยฃ2.31 Million-38.53%
1999 -ยฃ3.76 Million-18.43%
1998 -ยฃ4.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.44 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.94 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.86 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.7 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.51 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.62 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.08 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA